[1]
Pednekar, A. et al. 2024. The MeViDa Study: Bioequivalence Study of FDC of Dapagliflozin, Vildagliptin SR and Metformin SR in Healthy Indian Volunteers: A Randomized, Open-Label, Crossover Study. Journal of Drug Delivery and Therapeutics. 14, 7 (Jul. 2024), 1–5. DOI:https://doi.org/10.22270/jddt.v14i7.6674.